Published in
Massachusetts Medical Society, New England Journal of Medicine, 5(383), p. 498-500, 2020
DOI: 10.1056/nejmc2005943
Links
Tools
Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 